Tweetovi

Blokirali ste korisnika/cu @TBattelino

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TBattelino

  1. proslijedio/la je Tweet
    31. sij

    Great workshop today from my colleague Dr Dominic Bray. Great to hear all of the amazing work happening in paediatric diabetes. Here are a few of the good things we heard in response to “so... what’s going well already?” :

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    31. sij

    won’t stop academic collaborations with colleagues in Europe and around the world...

    Poništi
  3. proslijedio/la je Tweet
    24. sij

    Access the updated 2020 Standards of Medical Care in Diabetes app now!

    Poništi
  4. proslijedio/la je Tweet

    In India, disease incidence is rising. A new Helmsley grant will screen patients in need, help raise awareness, and prevent misdiagnosis of the disease: Pictured, Dr. Rupa Banerjee, lead PI on the grant project.

    Poništi
  5. proslijedio/la je Tweet
    24. sij

    Another day filming modules for the education modules for CGM and closed loop with . Thanks for your expert presentations: look out for news on launch

    Poništi
  6. 28. sij

    Dear Twitting friends: isCGM is now reimbursed for all individuals administrating three or more doses per day in 🌺 please rejoice w our PWDs 💕

    Poništi
  7. 22. sij
    Poništi
  8. 14. pro 2019.

    Prof Biffi: gene therapies work in clinical routine and have potential also in

    Poništi
  9. 14. pro 2019.

    Piemonti: “the individual who’s will be cured by cell therapies is alredy born” ❣️👍🏿👊🏾🌺

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    13. pro 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    published the variations in care to access in technology for children with and it has to stop...

    Poništi
  11. proslijedio/la je Tweet
    14. pro 2019.

    Better glycaemic variability and time in range with dapagliflozin vs gliclazide MR in T2 diabetes- is it of clinical significance?

    Poništi
  12. 14. pro 2019.

    Prof Lorenzo Piemonti on cell therapies for type 1 “we are closer to success” 👍🏿🌺

    Prikaži ovu nit
    Poništi
  13. 14. pro 2019.

    Prof Daniela Bruttomesso on the future technologies

    Poništi
  14. proslijedio/la je Tweet

    “Control-IQ clearance isn’t a step for automated insulin delivery, it’s a leap,” said CEO, John Sheridan.

    Poništi
  15. proslijedio/la je Tweet
    13. pro 2019.

    Today’s authorization by the U.S. Food and Drug Administration () of the Tandem Control-IQ algorithm for use as part of a hybrid closed-loop system is a win for the community!

    Poništi
  16. proslijedio/la je Tweet
    13. pro 2019.
    Poništi
  17. proslijedio/la je Tweet
    13. pro 2019.

    Elections are over- the year is drawing to a close. Heads together with the dream team to plan the year ahead in care ...and oh aren’t they ambitious indeed 😊 Just like the days of

    Poništi
  18. proslijedio/la je Tweet
    13. pro 2019.

    When you've been working hard &your (time in range) percentage hs steadily increased since early November - and then BOOM, you find yourself smack dab in the middle of day 2 of craptastical numbers.

    Poništi
  19. 14. pro 2019.

    Prof Ram Weis: we should be humble in our promises to people with about T1D prevention as we do not understand the disease 👏🏻❣️

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·